Ignite Creation Date:
2025-12-25 @ 4:45 AM
Ignite Modification Date:
2026-01-28 @ 6:52 PM
Study NCT ID:
NCT02195518
Status:
COMPLETED
Last Update Posted:
2019-11-04
First Post:
2014-07-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-17
First Submit QC Date:
None
Study First Post Date:
2014-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-17
Results First Submit QC Date:
None
Results First Post Date:
2019-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-15
Last Update Post Date:
2019-11-04
Last Update Post Date Type:
ACTUAL